Effect of ergocalciferol supplementation on peritonitis among peritoneal dialysis : a randomized controlled trial.
Not Applicable
- Conditions
- continuous ambulatory peritoneal dialysis patientsCAPDPeritonitisvitamin d deficiency
- Registration Number
- TCTR20191109001
- Lead Sponsor
- Dialysis unit, department of medicine, kalasin hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
ESRD on CAPD and stable run CAPD more than one month.
Exclusion Criteria
previous vitamin d intake
previous peritonitis 3 months
active cancer
hypercalcemia with serum calcium >10.5 mg/dL
iPTH < 50 pg/ml
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method peritonitis event 24 weeks Logrank test
- Secondary Outcome Measures
Name Time Method Death from any cause infection 24 weeks Logrank test ,CVD death 24 weeks logrank test ,secondary hyperparathyroidism 24 weeks Z-test ,falling 24 weeks Z-test ,fracture 24 weeks Z-test ,depression 24 weeks Z-test ,anemia 24 weeks Z-test